AbbVie
ABBV
#33
Rank
$414.77 B
Marketcap
$234.76
Share price
2.07%
Change (1 day)
28.85%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

AbbVie (ABBV) - Total assets

Total assets on the balance sheet as of March 2026 : $136.46 Billion USD

According to AbbVie's latest financial reports the company's total assets are $136.46 Billion USD. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

AbbVie - Total assets on balance sheet (from 2011 to 2026)

Total assets by year

Year Total assets Change
2025-12-31$133.96 B-0.89%
2024-12-31$135.16 B0.33%
2023-12-31$134.71 B-2.95%
2022-12-31$138.80 B-5.27%
2021-12-31$146.52 B-2.68%
2020-12-31$150.56 B68.96%
2019-12-31$89.11 B50.15%
2018-12-31$59.35 B-16.15%
2017-12-31$70.78 B7.09%
2016-12-31$66.09 B24.6%
2015-12-31$53.05 B92.82%
2014-12-31$27.51 B-5.77%
2013-12-31$29.19 B8.11%
2012-12-31$27.00 B38.35%
2011-12-31$19.52 B-7.64%
2010-12-31$21.13 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Pfizer
PFE
$207.61 B 52.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
$116.57 B-14.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
$92.50 B-32.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
$29.48 B-78.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
$56.27 B-58.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
$86.47 B-36.63%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
$114.01 B-16.45%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
$83.25 B-38.99%๐Ÿ‡ฌ๐Ÿ‡ง UK
Neurocrine Biosciences
NBIX
$4.90 B-96.40%๐Ÿ‡บ๐Ÿ‡ธ USA